{"id":"https://openalex.org/W3096428124","doi":"https://doi.org/10.1007/s00280-020-04153-6","title":"Effect of lurbinectedin on the QTc interval in patients with advanced solid tumors: an exposure\u2013response analysis","display_name":"Effect of lurbinectedin on the QTc interval in patients with advanced solid tumors: an exposure\u2013response analysis","publication_year":2020,"publication_date":"2020-10-27","ids":{"openalex":"https://openalex.org/W3096428124","doi":"https://doi.org/10.1007/s00280-020-04153-6","mag":"3096428124","pmid":"https://pubmed.ncbi.nlm.nih.gov/33108504","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7801313"},"language":"en","primary_location":{"id":"doi:10.1007/s00280-020-04153-6","doi":"https://doi.org/10.1007/s00280-020-04153-6","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00280-020-04153-6","pdf_url":null,"source":{"id":"https://openalex.org/S117498271","display_name":"Cancer Chemotherapy and Pharmacology","issn_l":"0344-5704","issn":["0344-5704","1432-0843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Chemotherapy and Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1007/s00280-020-04153-6","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030621386","display_name":"Salvador Fudio","orcid":"https://orcid.org/0000-0001-7320-6139","observed_orcids":["https://orcid.org/0000-0001-7320-6139"]},"institutions":[{"id":"https://openalex.org/I4210116403","display_name":"PharmaMar (Spain)","ror":"https://ror.org/02h694m69","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210116403"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Salvador Fudio","raw_affiliation_strings":["PharmaMar, Avda. De los Reyes, 1, Pol. Ind. La Mina-Norte, Colmenar Viejo, Madrid, 28770, Spain. sfudio@pharmamar.com","PharmaMar, Avda. De los Reyes, 1, Pol. Ind. La Mina-Norte, Colmenar Viejo, Madrid, 28770, Spain"],"raw_orcid":"https://orcid.org/0000-0001-7320-6139","affiliations":[{"raw_affiliation_string":"PharmaMar, Avda. De los Reyes, 1, Pol. Ind. La Mina-Norte, Colmenar Viejo, Madrid, 28770, Spain. sfudio@pharmamar.com","institution_ids":["https://openalex.org/I4210116403"]},{"raw_affiliation_string":"PharmaMar, Avda. De los Reyes, 1, Pol. Ind. La Mina-Norte, Colmenar Viejo, Madrid, 28770, Spain","institution_ids":["https://openalex.org/I4210116403"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015190461","display_name":"Josep M. Tabernero","orcid":"https://orcid.org/0000-0002-2495-8139","observed_orcids":["https://orcid.org/0000-0002-2495-8139"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Josep Tabernero","raw_affiliation_strings":["Vall d'Hebr\u00f3n University Hospital and Institute of Oncology (VHIO), 08035, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vall d'Hebr\u00f3n University Hospital and Institute of Oncology (VHIO), 08035, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641","https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043675371","display_name":"Vivek Subbiah","orcid":"https://orcid.org/0000-0002-6064-6837","observed_orcids":["https://orcid.org/0000-0002-6064-6837"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vivek Subbiah","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073906112","display_name":"Sant P. Chawla","orcid":"https://orcid.org/0000-0002-9522-6744","observed_orcids":["https://orcid.org/0000-0002-9522-6744"]},"institutions":[{"id":"https://openalex.org/I4210104185","display_name":"Sarcoma Oncology Center","ror":"https://ror.org/01k15w004","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210104185"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sant P. Chawla","raw_affiliation_strings":["Sarcoma Oncology Center, Santa Monica, CA, 90403, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarcoma Oncology Center, Santa Monica, CA, 90403, USA","institution_ids":["https://openalex.org/I4210104185"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006299989","display_name":"V\u00edctor Moreno","orcid":"https://orcid.org/0000-0001-6099-4236","observed_orcids":["https://orcid.org/0000-0001-6099-4236"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Victor Moreno","raw_affiliation_strings":["Fundaci\u00f3n Jim\u00e9nez D\u00edaz, 28040, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fundaci\u00f3n Jim\u00e9nez D\u00edaz, 28040, Madrid, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080562953","display_name":"Federico Longo","orcid":"https://orcid.org/0000-0003-0902-2188","observed_orcids":["https://orcid.org/0000-0003-0902-2188"]},"institutions":[{"id":"https://openalex.org/I4210161852","display_name":"Hospital Universitario Ram\u00f3n y Cajal","ror":"https://ror.org/050eq1942","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210139293","https://openalex.org/I4210161852"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Federico Longo","raw_affiliation_strings":["Hospital Ramon y Cajal, 28034, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Ramon y Cajal, 28034, Madrid, Spain","institution_ids":["https://openalex.org/I4210161852"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005025032","display_name":"Rafael L\u00f3pez\u2010L\u00f3pez","orcid":"https://orcid.org/0000-0002-2240-6277","observed_orcids":["https://orcid.org/0000-0002-2240-6277"]},"institutions":[{"id":"https://openalex.org/I4210148771","display_name":"Instituto de Investigaci\u00f3n Sanitaria de Santiago","ror":"https://ror.org/05n7xcf53","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210148771"]},{"id":"https://openalex.org/I4210158561","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer","ror":"https://ror.org/04hya7017","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210158561"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Rafael Lopez","raw_affiliation_strings":["IDIS, CIBERONC, Hospital Cl\u00ednico Universitario de Santiago de Compostela, 15706, Santiago De Compostela, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IDIS, CIBERONC, Hospital Cl\u00ednico Universitario de Santiago de Compostela, 15706, Santiago De Compostela, Spain","institution_ids":["https://openalex.org/I4210148771","https://openalex.org/I4210158561"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090790623","display_name":"Antonio Ant\u00f3n","orcid":"https://orcid.org/0000-0002-2802-6232","observed_orcids":["https://orcid.org/0000-0002-2802-6232"]},"institutions":[{"id":"https://openalex.org/I4210114530","display_name":"Hospital Universitario Miguel Servet","ror":"https://ror.org/01r13mt55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210114530"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Antonio Anton","raw_affiliation_strings":["Hospital Universitario Miguel Servet, 50009, Zaragoza, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario Miguel Servet, 50009, Zaragoza, Spain","institution_ids":["https://openalex.org/I4210114530"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062111870","display_name":"Jos\u00e9 Manuel Trigo","orcid":"https://orcid.org/0000-0002-4489-2683","observed_orcids":["https://orcid.org/0000-0002-4489-2683"]},"institutions":[{"id":"https://openalex.org/I4210157481","display_name":"Hospital Cl\u00ednico Universitario Virgen de la Victoria","ror":"https://ror.org/05xxs2z38","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I158283456","https://openalex.org/I4210157481"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jose Manuel Trigo","raw_affiliation_strings":["Hospital Virgen de la Victoria, 29010, M\u00e1laga, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Virgen de la Victoria, 29010, M\u00e1laga, Spain","institution_ids":["https://openalex.org/I4210157481"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045419282","display_name":"Geoffrey Ira Shapiro","orcid":"https://orcid.org/0000-0002-3331-4095","observed_orcids":["https://orcid.org/0000-0002-3331-4095"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Geoffrey Shapiro","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA, 02215, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA, 02215, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036220598","display_name":"Woondong Jeong","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Woondong Jeong","raw_affiliation_strings":["Cancer Therapy and Research Center, San Antonio, TX, 78229, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Therapy and Research Center, San Antonio, TX, 78229, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045901657","display_name":"Victor Manuel Villalobos","orcid":"https://orcid.org/0000-0002-8722-284X","observed_orcids":["https://orcid.org/0000-0002-8722-284X"]},"institutions":[{"id":"https://openalex.org/I921990950","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24","country_code":"US","type":"education","lineage":["https://openalex.org/I921990950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Victor Manuel Villalobos","raw_affiliation_strings":["University of Colorado, Denver, CO, 80045, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Colorado, Denver, CO, 80045, USA","institution_ids":["https://openalex.org/I921990950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036714492","display_name":"Rubin Lubomirov","orcid":"https://orcid.org/0000-0003-0550-8228","observed_orcids":["https://orcid.org/0000-0003-0550-8228"]},"institutions":[{"id":"https://openalex.org/I4210116403","display_name":"PharmaMar (Spain)","ror":"https://ror.org/02h694m69","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210116403"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Rubin Lubomirov","raw_affiliation_strings":["PharmaMar, Avda. De los Reyes, 1, Pol. Ind. La Mina-Norte, Colmenar Viejo, Madrid, 28770, Spain"],"raw_orcid":"https://orcid.org/0000-0003-0550-8228","affiliations":[{"raw_affiliation_string":"PharmaMar, Avda. De los Reyes, 1, Pol. Ind. La Mina-Norte, Colmenar Viejo, Madrid, 28770, Spain","institution_ids":["https://openalex.org/I4210116403"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090638552","display_name":"Carlos Fern\u00e1ndez\u2010Teruel","orcid":"https://orcid.org/0000-0002-1473-2267","observed_orcids":["https://orcid.org/0000-0002-1473-2267"]},"institutions":[{"id":"https://openalex.org/I4210116403","display_name":"PharmaMar (Spain)","ror":"https://ror.org/02h694m69","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210116403"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Carlos Fernandez-Teruel","raw_affiliation_strings":["PharmaMar, Avda. De los Reyes, 1, Pol. Ind. La Mina-Norte, Colmenar Viejo, Madrid, 28770, Spain"],"raw_orcid":"https://orcid.org/0000-0002-1473-2267","affiliations":[{"raw_affiliation_string":"PharmaMar, Avda. De los Reyes, 1, Pol. Ind. La Mina-Norte, Colmenar Viejo, Madrid, 28770, Spain","institution_ids":["https://openalex.org/I4210116403"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048398150","display_name":"Vicente Alfaro","orcid":"https://orcid.org/0000-0002-0150-2390","observed_orcids":["https://orcid.org/0000-0002-0150-2390"]},"institutions":[{"id":"https://openalex.org/I4210116403","display_name":"PharmaMar (Spain)","ror":"https://ror.org/02h694m69","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210116403"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Vicente Alfaro","raw_affiliation_strings":["PharmaMar, Avda. De los Reyes, 1, Pol. Ind. La Mina-Norte, Colmenar Viejo, Madrid, 28770, Spain"],"raw_orcid":"https://orcid.org/0000-0002-0150-2390","affiliations":[{"raw_affiliation_string":"PharmaMar, Avda. De los Reyes, 1, Pol. Ind. La Mina-Norte, Colmenar Viejo, Madrid, 28770, Spain","institution_ids":["https://openalex.org/I4210116403"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5020352800","display_name":"Valentina Boni","orcid":"https://orcid.org/0000-0002-8675-0018","observed_orcids":["https://orcid.org/0000-0002-8675-0018"]},"institutions":[{"id":"https://openalex.org/I4210137474","display_name":"Hospital Universitario HM Sanchinarro","ror":"https://ror.org/04jep6391","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210122338","https://openalex.org/I4210137474"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Valentina Boni","raw_affiliation_strings":["START Madrid-CIOCC, Hospital Universitario San Chinarro, 28050, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"START Madrid-CIOCC, Hospital Universitario San Chinarro, 28050, Madrid, Spain","institution_ids":["https://openalex.org/I4210137474"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":13,"corresponding_author_ids":["https://openalex.org/A5030621386"],"corresponding_institution_ids":["https://openalex.org/I4210116403"],"apc_list":{"value":3860,"currency":"USD","value_usd":3860},"apc_paid":{"value":3860,"currency":"USD","value_usd":3860},"fwci":0.4857,"has_fulltext":true,"cited_by_count":6,"citation_normalized_percentile":{"value":0.63621296,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"87","issue":"1","first_page":"113","last_page":"124"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10217","display_name":"Cardiac electrophysiology and arrhythmias","score":0.6934000253677368,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10217","display_name":"Cardiac electrophysiology and arrhythmias","score":0.6934000253677368,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.23649999499320984,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.007499999832361937,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lurbinectedin","display_name":"lurbinectedin","score":1.0},{"id":"https://openalex.org/keywords/qtc-interval","display_name":"QTc interval","score":0.8809999823570251},{"id":"https://openalex.org/keywords/cardiac-repolarization","display_name":"cardiac repolarization","score":0.8399999737739563},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.7009999752044678},{"id":"https://openalex.org/keywords/exposure-response-relationship","display_name":"exposure-response relationship","score":0.6769999861717224},{"id":"https://openalex.org/keywords/effect-compartment-model","display_name":"effect compartment model","score":0.7310000061988831},{"id":"https://openalex.org/keywords/plasma-drug-concentration","display_name":"plasma drug concentration","score":0.5519999861717224},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.4129999876022339}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8709658980369568},{"id":"https://openalex.org/C118441451","wikidata":"https://www.wikidata.org/wiki/Q12074763","display_name":"QT interval","level":2,"score":0.8241884708404541},{"id":"https://openalex.org/C111773187","wikidata":"https://www.wikidata.org/wiki/Q1969239","display_name":"QRS complex","level":2,"score":0.5401867628097534},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.46992719173431396},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4456444978713989},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.43200045824050903},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3449289798736572}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D002243","descriptor_name":"Carbolines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002243","descriptor_name":"Carbolines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D002243","descriptor_name":"Carbolines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D004562","descriptor_name":"Electrocardiography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006576","descriptor_name":"Heterocyclic Compounds, 4 or More Rings","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006576","descriptor_name":"Heterocyclic Compounds, 4 or More Rings","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D006576","descriptor_name":"Heterocyclic Compounds, 4 or More Rings","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":7,"locations":[{"id":"doi:10.1007/s00280-020-04153-6","doi":"https://doi.org/10.1007/s00280-020-04153-6","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00280-020-04153-6","pdf_url":null,"source":{"id":"https://openalex.org/S117498271","display_name":"Cancer Chemotherapy and Pharmacology","issn_l":"0344-5704","issn":["0344-5704","1432-0843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Chemotherapy and Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:6723460","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC7801313","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmid:33108504","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33108504","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer chemotherapy and pharmacology","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:dnet:zaguan______::e10f4829503a3d7056b2814c346eee66","doi":null,"is_oa":true,"landing_page_url":"http://zaguan.unizar.es/record/97222","pdf_url":null,"source":{"id":"https://openalex.org/S4306402641","display_name":"LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Cient\u00edficas)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4383465926","host_organization_name":"LA Referencia","host_organization_lineage":["https://openalex.org/I4383465926"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7801313","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7801313/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Chemother Pharmacol","raw_type":"Text"},{"id":"pmh:oai:www.repositoriosalud.es:10668/16488","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801313/pdf","pdf_url":"https://link.springer.com/content/pdf/10.1007/s00280-020-04153-6.pdf","source":{"id":"https://openalex.org/S4377196114","display_name":"RISalud Institutional Health Repository of Andaluc\u00eda","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"research article"},{"id":"pmh:oai:zaguan.unizar.es:97222","doi":null,"is_oa":true,"landing_page_url":"http://zaguan.unizar.es/record/97222","pdf_url":"http://zaguan.unizar.es/record/97222","source":{"id":"https://openalex.org/S4306402461","display_name":"Zaguan (Universidad de Zaragoza)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I255234318","host_organization_name":"Universidad de Zaragoza","host_organization_lineage":["https://openalex.org/I255234318"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1007/s00280-020-04153-6","doi":"https://doi.org/10.1007/s00280-020-04153-6","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00280-020-04153-6","pdf_url":null,"source":{"id":"https://openalex.org/S117498271","display_name":"Cancer Chemotherapy and Pharmacology","issn_l":"0344-5704","issn":["0344-5704","1432-0843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Chemotherapy and Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G5153049905","display_name":null,"funder_award_id":"IDI-20150006","funder_id":"https://openalex.org/F4320321043","funder_display_name":"Centro para el Desarrollo Tecnol\u00f3gico Industrial"}],"funders":[{"id":"https://openalex.org/F4320321043","display_name":"Centro para el Desarrollo Tecnol\u00f3gico Industrial","ror":"https://ror.org/0124x7055"},{"id":"https://openalex.org/F4320327811","display_name":"PharmaMar","ror":"https://ror.org/02h694m69"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3096428124.pdf","grobid_xml":"https://content.openalex.org/works/W3096428124.grobid-xml"},"referenced_works_count":17,"referenced_works":["https://openalex.org/W43308025","https://openalex.org/W1603105736","https://openalex.org/W1909306694","https://openalex.org/W1978647133","https://openalex.org/W2015116906","https://openalex.org/W2027346433","https://openalex.org/W2080215255","https://openalex.org/W2130862071","https://openalex.org/W2153906296","https://openalex.org/W2166723281","https://openalex.org/W2169197323","https://openalex.org/W2284531888","https://openalex.org/W2518722917","https://openalex.org/W2771291368","https://openalex.org/W2886110422","https://openalex.org/W3063858912","https://openalex.org/W4292004352"],"related_works":["https://openalex.org/W2015711868","https://openalex.org/W2953039586","https://openalex.org/W2999704745","https://openalex.org/W2794978218","https://openalex.org/W2955207585","https://openalex.org/W2604307041","https://openalex.org/W2002178750","https://openalex.org/W2080215255","https://openalex.org/W2079134803","https://openalex.org/W2423170456"],"abstract_inverted_index":{"Abstract":[0],"Purpose":[1],"This":[2],"study":[3,233],"assessed":[4],"the":[5,17,113,118,166,177,185,205,217],"effect":[6,106,201,244],"of":[7,13,117,148,165,169,208,221],"lurbinectedin,":[8],"a":[9,68,241],"highly":[10],"selective":[11],"inhibitor":[12],"oncogenic":[14],"transcription,":[15],"on":[16,107,245],"change":[18],"from":[19,153],"baseline":[20],"in":[21,37,78,84,192,230],"Fridericia\u2019s":[22],"corrected":[23],"QT":[24,190],"interval":[25,109],"(\u2206QTcF)":[26],"and":[27,32,58,62,88,90,204,227],"electrocardiography":[28],"(ECG)":[29],"morphological":[30],"patterns,":[31],"lurbinectedin":[33,65,102,236],"concentration\u2013\u2206QTcF":[34],"(C-\u2206QTcF)":[35],"relationship,":[36],"patients":[38,155],"with":[39,45,240],"advanced":[40],"solid":[41],"tumors.":[42],"Methods":[43],"Patients":[44],"QTcF":[46],"\u2264":[47],"500":[48],"ms,":[49,53,57,173,214],"QRS":[50],"<":[51,55,135],"110":[52],"PR":[54],"200":[56],"normal":[59],"cardiac":[60,246],"conduction":[61],"function":[63],"received":[64],"3.2":[66],"mg/m2as":[67],"1-h":[69],"intravenous":[70],"infusion":[71],"every":[72],"3":[73],"weeks.":[74],"ECGs":[75,150],"were":[76,98,151],"collected":[77,152],"triplicate":[79],"via":[80],"12-lead":[81],"digital":[82],"recorder":[83],"treatment":[85],"cycle":[86],"1":[87],"2":[89],"analyzed":[91],"centrally.":[92],"ECG":[93,225],"collection":[94],"time-matched":[95],"blood":[96],"samples":[97],"drawn":[99],"to":[100],"measure":[101],"plasma":[103],"concentration.":[104],"No":[105],"QTc":[108],"was":[110,134,139,171,196,237],"concluded":[111],"if":[112],"upper":[114],"bound":[115],"(UB)":[116],"least":[119],"square":[120],"(LS)":[121],"mean":[122],"two-sided":[123],"90%":[124,167,206],"confidence":[125],"intervals":[126],"(CI)":[127],"for":[128,189],"\u0394QTcF":[129,170,210],"at":[130,184,211],"each":[131],"time":[132],"point":[133],"20":[136],"ms.":[137],"C-\u2206QTcF":[138,195],"explored":[140],"using":[141],"linear":[142],"mixed-effects":[143],"analysis.":[144],"Results":[145],"A":[146],"total":[147],"1707":[149],"39":[154],"(females,":[156],"22;":[157],"median":[158],"age,":[159],"56":[160],"years).":[161],"The":[162],"largest":[163],"UB":[164],"CI":[168,207],"9.6":[172],"thus":[174],"lower":[175],"than":[176],"more":[178],"conservative":[179],"10":[180,218],"ms":[181,219],"threshold":[182,220],"established":[183],"ICH":[186],"E14":[187],"guideline":[188],"studies":[191],"healthy":[193],"volunteers.":[194],"better":[197],"fit":[198],"by":[199],"an":[200],"compartment":[202],"model,":[203],"predicted":[209],"Cmaxwas":[212],"7.81":[213],"also":[215],"below":[216],"clinical":[222],"concern.":[223],"Conclusions":[224],"parameters":[226],"C-\u0394QTcF":[228],"modelling":[229],"this":[231],"prospective":[232],"indicate":[234],"that":[235],"not":[238],"associated":[239],"clinically":[242],"relevant":[243],"repolarization.":[247]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2020,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2020-11-09T00:00:00"}